Métastases osseuses et cancer pulmonaire (notice n° 271434)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02441cam a2200289 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112080555.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Morardet, Laetitia |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Métastases osseuses et cancer pulmonaire |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2020.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 60 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméLes métastases osseuses font partie de l’histoire naturelle des cancers bronchiques. Souvent présentes au diagnostic, environ un patient sur trois est confronté à une métastase osseuse au cours de sa maladie. Ces métastases sont responsables de complications, telles que des douleurs, fractures, compressions médullaires, hypercalcémies ou encore la nécessité d’une radiothérapie antalgique ou d’une chirurgie préventive. Les conséquences sont une altération de la qualité de vie et une augmentation de la morbidité. Des possibilités thérapeutiques osseuses systémiques et locales existent et méritent d’être mises en œuvre dans les cancers bronchopulmonaires, pour lesquels l’espérance de vie s’est considérablement améliorée ces dernières années avec l’avènement de la biologie moléculaire, des thérapies ciblées et de l’immunothérapie. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Bone metastases are part of the natural history of lung cancer. One in three patients will experience bone metastasis during the course of the disease. These metastases are responsible for complications such as pain, fractures, spinal cord compression, and hypercalcaemia, and may require analgesic radiotherapy or preventative surgery. The consequences are a decrease in quality of life and increase in morbidity. Possible systemic and local bone therapies exist and should be implemented in cases of lung cancer, for which life expectancy has improved considerably in recent years with the advent of molecular biology, targeted therapies and immunotherapy. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ) |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | SRE ( |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Skeletal Related Event |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer pulmonaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | métastases osseuses |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | SRE (Skeletal Related Event) |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | lung cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | bone metastasis |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thureau, Sébastien |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vieillard, Marie-Hélène |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Innovations & Thérapeutiques en Oncologie | Volume 6 | 3 | 2020-05-01 | p. 133-137 | 2431-3203 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2020-3-page-133?lang=fr">https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2020-3-page-133?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux